Clinical Coagulation, Malmö
81 – 90 of 630
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Optimising prophylaxis in haemophilia A : The ups and downs of treatment
(
- Contribution to journal › Scientific review
-
Mark
Severe Congenital Thrombocytopenia Characterized by Decreased Platelet Sialylation and Moderate Complement Activation Caused by Novel Compound Heterozygous Variants in GNE
(
- Contribution to journal › Article
-
Mark
Amino acids predict prognosis in patients with acute dyspnea
(
- Contribution to journal › Article
-
Mark
In response to WFH guidelines for the management of haemophilia, 3rd edition : Is there a difference between extended-half-life FVIII products or not?
(
- Contribution to journal › Letter
-
Mark
Thrombotic Risk Determined by STAB 2 Variants in a Population-Based Cohort Study
(
- Contribution to journal › Letter
-
Mark
Natural history study of factor IX deficiency with focus on treatment and complications (B-Natural)
(
- Contribution to journal › Article
-
Mark
Evaluating the Risk of Digitalis Intoxication Associated With Concomitant Use of Dronedarone and Digoxin Using Real-World Data
(
- Contribution to journal › Article
-
Mark
Genetic Screening in Patients Suspected of Inherited Bleeding Disorders
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Evaluation of the Sialidase Inhibitor Oseltamivir in GNE-associated Thrombocytopenia
2021) The XXIX Congress of the International Society on Thrombosis and Haemostasis (ISTH) In Research and practice in thrombosis and haemostasis 5(S2). p.644-645(
- Contribution to journal › Published meeting abstract
-
Mark
A simplified decision rule to rule out deep vein thrombosis using clinical assessment and D-dimer
(
- Contribution to journal › Article